Emil deGoma, MD

ChemoCentryx
San Carlos, CA, United States

Senior Vice President, Clinical Development, ChemoCentryx, Inc.

Disclosure information not submitted.

Presentation(s):

• 1078: Glucocorticoid Use and Related Adverse Events in ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time